港股異動丨匯森家居(2127.HK)大漲逾13%再創新高 上市4日升幅近40%
格隆匯1月4日丨次新股匯森家居(2127.HK)上市4日累計漲幅近40%,今日高見2.46港元再創上市新高價,漲13.49%,總市值73.2億港元。該股IPO公開發售獲53.4倍認購。在此次IPO中,匯森家居成功引入了7名基石投資者,認購總額約6.21億港元的股份,佔國配部分近一半的比例。此次成功登陸港股市場,匯森家居這個板式傢俱出口龍頭也將迎來新的成長機遇。招股書顯示,公司淨利潤由2017年的3.35億增長到2019年的5.68億,複合年增長率為30.3%。隨着無甲醛釋放面板工藝的突破,匯森家居也將在後續的市場競爭中佔得先機。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.